Biomark Diagnostics Inc. (FRA:20B)

Biomark Diagnostics Revenue

Biomark Diagnostics had revenue of 6.92K CAD in the quarter ending December 31, 2025, a decrease of -82.07%. This brings the company's revenue in the last twelve months to 91.77K, down -40.80% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.

• Revenue (ttm): 91.77K CAD
• Revenue Growth: -40.80%
• P/S Ratio: 590.28
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 33.65M EUR

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	154.22K	-9.00K	-5.52%
Mar 31, 2024	163.22K	9.73K	6.34%
Mar 31, 2023	153.49K	109.56K	249.38%
Mar 31, 2022	43.93K	-	-
Mar 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error